These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 9044461

  • 1. Early elevation of lipoprotein(a) levels in chronic renal insufficiency.
    De Lima JJ, Maranhão RC, Latrilha Mda C, Diament J, Romão JE, Krieger EM, Pileggi F.
    Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporin A has divergent effects on plasma LDL cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] levels in renal transplant recipients. Evidence for renal involvement in the maintenance of LDL-C and the elevation of Lp(a) concentrations in hemodialysis patients.
    Azrolan N, Brown CD, Thomas L, Hayek T, Zhao ZH, Roberts KG, Scheiner C, Friedman EA.
    Arterioscler Thromb; 1994 Sep; 14(9):1393-8. PubMed ID: 8068598
    [Abstract] [Full Text] [Related]

  • 3. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
    Brown JH, Murphy BG, Douglas AF, Short CD, Bhatnagar D, Mackness MI, Hunt LP, Doherty CC, Durrington PN.
    Nephron; 1997 Sep; 75(3):277-82. PubMed ID: 9069448
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC.
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein (a) levels in end-stage renal failure and renal transplantation.
    Barbagallo CM, Averna MR, Sparacino V, Galione A, Caputo F, Scafidi V, Amato S, Mancino C, Cefalù AB, Notarbartolo A.
    Nephron; 1993 Jun; 64(4):560-4. PubMed ID: 8366981
    [Abstract] [Full Text] [Related]

  • 6. Serum lipoprotein (a) levels in patients with chronic renal failure--evolution after renal transplantation and relationship with other parameters of lipoprotein metabolism: a prospective study.
    Segarra A, Chacón P, Martin M, Vilardell M, Vila J, Cotrina M, Fort J, Olmos A, Piera LL.
    Nephron; 1995 Jun; 69(1):9-13. PubMed ID: 7891807
    [Abstract] [Full Text] [Related]

  • 7. Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy.
    Brown JH, Anwar N, Short CD, Bhatnager D, Mackness MI, Hunt LP, Durrington PN.
    Nephrol Dial Transplant; 1993 Jun; 8(9):863-7. PubMed ID: 8255521
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E.
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P, Berglund L.
    Miner Electrolyte Metab; 1996 Sep; 22(1-3):16-21. PubMed ID: 8676811
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Schärer K.
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [Abstract] [Full Text] [Related]

  • 11. Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.
    Kandoussi A, Cachera C, Pagniez D, Dracon M, Fruchart JC, Tacquet A.
    Kidney Int; 1992 Aug; 42(2):424-5. PubMed ID: 1405325
    [Abstract] [Full Text] [Related]

  • 12. Decrease in lipoprotein(a) after renal transplantation is related to the glucocorticoid dose.
    von Ahsen N, Helmhold M, Eisenhauer T, Armstrong VW, Oellerich M.
    Eur J Clin Invest; 1996 Aug; 26(8):668-75. PubMed ID: 8872062
    [Abstract] [Full Text] [Related]

  • 13. Increased lipoprotein(a) concentrations in chronic renal failure.
    Haffner SM, Gruber KK, Aldrete G, Morales PA, Stern MP, Tuttle KR.
    J Am Soc Nephrol; 1992 Nov; 3(5):1156-62. PubMed ID: 1482754
    [Abstract] [Full Text] [Related]

  • 14. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J.
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [Abstract] [Full Text] [Related]

  • 15. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ, Elisaf MS, Karabina SA, Bairaktari E, Tselepis AD, Siamopoulos KC.
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [Abstract] [Full Text] [Related]

  • 16. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B.
    Nephron; 1996 Dec; 72(2):135-44. PubMed ID: 8684516
    [Abstract] [Full Text] [Related]

  • 17. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
    Kimak E, Solski J.
    Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
    [Abstract] [Full Text] [Related]

  • 18. Serum lipoprotein (a) levels in maintenance hemodialysis patients.
    Okura Y, Saku K, Hirata K, Zhang B, Liu R, Ogahara S, Naito S, Kajiyama G, Arakawa K.
    Nephron; 1993 Jul; 65(1):46-50. PubMed ID: 8413789
    [Abstract] [Full Text] [Related]

  • 19. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
    Zwolińska D, Kiliś-Pstrusińska K, Szprynger K.
    Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
    [Abstract] [Full Text] [Related]

  • 20. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J, Janicka L, Ksaziek A, Janicki K.
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.